SCHEMBL30337267

SCHEMBL30337267

Cn1cc(-c2nc(Cl)nc3ccsc23)c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.49
ADORA1 P30542 2/20 0.49
CDK5 Q00535 2/20 0.45
CDK5R1 Q15078 2/20 0.45
ALDH1A1 P00352 4/20 0.42
LMNA P02545 2/20 0.42
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MEN1 O00255 5/20 0.41
USP2 O75604 5/20 0.41
CYP1A2 P05177 5/20 0.41
KMT2A Q03164 5/20 0.41
CASP1 P29466 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21195010 1.00 ADORA2A (0.49) ADORA2AADORA1CDK5CDK5R1ALDH1A1
SCHEMBL18921234 0.80 CDK5 (0.44) CDK5CDK5R1ALDH1A1LMNAKDM4E
SCHEMBL30957634 0.76 IMPDH2 (0.44) CDK5CDK5R1ALDH1A1LMNAKDM4E
SCHEMBL24900527 0.76 IMPDH2 (0.44) CDK5CDK5R1ALDH1A1LMNAKDM4E
SCHEMBL16613359 0.76 ADORA2A (0.56) ADORA2AADORA1ALDH1A1KDM4EMAPT
SCHEMBL3362091 0.72 KDM4E (0.63) ALDH1A1LMNAKDM4ENPC1MAPT
SCHEMBL29994241 0.72 CDK5 (0.53) CDK5CDK5R1ALDH1A1LMNAKDM4E
SCHEMBL517423 0.72 CDK5 (0.53) CDK5CDK5R1ALDH1A1LMNAKDM4E
SCHEMBL18921750 0.72 CDK7 (0.55) ADORA2AADORA1CDK5CDK5R1ALDH1A1
SCHEMBL14719082 0.71 CDK5 (0.52) CDK5CDK5R1ALDH1A1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115974845-B Preparation method of Ornitinib intermediate 奥锐特药业股份有限公司 2024-09-20 CN disclosed
CN-115974845-A Preparation method of oxitinib intermediate 奥锐特药业股份有限公司 2023-04-18 CN disclosed